Target intelligence / Profile preview

Fos proto-oncogene, AP-1 transcription factor subunit (FOS (or c-Fos))

Target
FOS (or c-Fos)
Molecular classification
Transcription factor, Proto-oncogene, Nuclear phosphoprotein
01

Overview

The Fos proto-oncogene, AP-1 transcription factor subunit encodes the nuclear phosphoprotein c-Fos, a member of the Fos family of transcription factors. It forms heterodimers with JUN family proteins via its leucine zipper domain to create the AP-1 complex, which binds specific DNA sequences at promoter/enhancer regions and regulates genes involved in cell growth, differentiation, survival, apoptosis, angiogenesis, and response to extracellular stimuli. Expression of c-Fos is rapidly induced by diverse signals including growth factors and stressors; it acts both as an activator and repressor depending on context. Dysregulation—especially overexpression—of c-Fos contributes significantly to oncogenic transformation across multiple cancer types through promotion of cell proliferation and invasion. The protein’s function is tightly controlled at multiple levels including rapid degradation via proteasome-mediated turnover.

Other names
c-FosProto-oncogene c-FosAP-1 transcription factor subunitFBJ murine osteosarcoma viral oncogene homolog
02

Mechanism of action

Drugs that affect FOS do so primarily by inhibiting upstream signaling pathways (e.g., MAPK/ERK), thereby reducing FOS gene expression or protein stability. Some anti-cancer strategies aim to disrupt dimerization with JUN proteins or block DNA binding of the AP-1 complex.

03

Biological functions

Regulation of gene expressionCell proliferationCell differentiationCell survivalApoptosis (cell death)Signal transduction
04

Disease associations

Cancer (oncogenesis in various tumor types)Bone disorders (skeletal development defects)Other developmental abnormalities
05

Safety considerations

Targeting transcription factors like FOS directly poses challenges due to their essential roles in normal cellular functions such as development and tissue homeostasis. Inhibition could lead to off-target effects including impaired bone formation, immune dysfunction, or developmental defects observed in animal models lacking functional c-Fos protein.
06

Interacting drugs

There are no direct small-molecule drugs that target FOS/c-Fos clinically; however, its activity is modulated indirectly by drugs affecting upstream pathways such as kinase inhibitors and anti-cancer agents targeting the MAPK pathway. COX inhibitors may also be relevant due to downstream effects on COX2 expression regulated by AP-1/c-Fos complexes.
07

Biomarkers

FOS/c-Fos overexpression is used as a biomarker for cell activation and proliferation in cancer research and sometimes for monitoring neuronal activity or immediate early gene response in experimental models. It can serve as a marker for aggressive tumor phenotypes in some cancers.

Beyond the preview

Go deeper on Fos proto-oncogene, AP-1 transcription factor subunit (FOS (or c-Fos)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fos proto-oncogene, AP-1 transcription factor subunit (FOS (or c-Fos)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call